AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
* A New Solution in Acne Clinically Proven to Improve Patient Satisfaction and Comfort
LONG BEACH, Calif. -- Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today the introduction of the newest addition to its clinically proven line of topical products to treat acne - CLENZIderm M.D.[TM] Acne Therapeutic System for Normal to Dry Skin. This simple three-step system, based on Obagi's patent-pending, solubilized benzoyl peroxide, penetrates deep and clears acne fast, while minimizing dryness and maximizing patient comfort.
Clinical studies show that when used just once per day, this therapeutic system reduces the inflammatory lesions by 50% and delivers a 29% reduction in non-inflammatory lesions within two weeks. The system's liquefied benzoyl peroxide is 1/10,000 the average…
Source: HighBeam Research, Obagi Medical Products Introduces CLENZIderm M.D. Acne Therapeutic...